Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/26 17:18 | 2/17/26 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 4 | S.d | -151 | 8.75 | 0 | -17 | 60 | D | |||||||||||||||
2/18/26 17:17 | 2/17/26 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC,Secre | 5 | S.d | -226 | 9.32 | 0 | -24 | 73 | D | |||||||||||||||
2/18/26 17:16 | 2/17/26 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO | 5 | S.d | -213 | 9.33 | 0 | -23 | 312 | D | |||||||||||||||
2/18/26 17:14 | 2/17/26 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 5 | S.d | -661 | 9.01 | 0 | -73 | 1,799 | D | |||||||||||||||
2/18/26 17:13 | 2/17/26 | DAWN | Health | Drug | Pharmaceutical Preparations | Vasconcelles Michael | CA | O | Head of | 1 | S.d | -32 | 11.60 | 0 | -3 | 4 | D | |||||||||||||||
12/12/24 16:06 | 12/10/24 | DAWN | Health | Drug | Pharmaceutical Preparations | Blackman Samuel C. | CA | O | HEAD OF | 1 | S | -399 | 13.31 | 0 | -30 | 2,034 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |